19-1254290-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001388306.1(MIDN):c.637G>A(p.Ala213Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,418,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001388306.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIDN | NM_001388306.1 | c.637G>A | p.Ala213Thr | missense_variant | 6/9 | ENST00000682408.1 | NP_001375235.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIDN | ENST00000682408.1 | c.637G>A | p.Ala213Thr | missense_variant | 6/9 | NM_001388306.1 | ENSP00000507955 | A2 | ||
MIDN | ENST00000591446.7 | c.508G>A | p.Ala170Thr | missense_variant | 4/7 | 1 | ENSP00000467679 | P2 | ||
MIDN | ENST00000300952.7 | c.508G>A | p.Ala170Thr | missense_variant | 5/8 | 5 | ENSP00000300952 | P2 | ||
MIDN | ENST00000590136.1 | n.523G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000271 AC: 5AN: 184278Hom.: 0 AF XY: 0.0000193 AC XY: 2AN XY: 103626
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1418452Hom.: 0 Cov.: 34 AF XY: 0.0000170 AC XY: 12AN XY: 704060
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.508G>A (p.A170T) alteration is located in exon 5 (coding exon 4) of the MIDN gene. This alteration results from a G to A substitution at nucleotide position 508, causing the alanine (A) at amino acid position 170 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at